Singapore markets closed

Agilent Technologies, Inc. (A)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
150.90-2.52 (-1.64%)
At close: 04:02PM EST
150.50 -0.40 (-0.27%)
After hours: 06:01PM EST

Agilent Technologies, Inc.

5301 Stevens Creek Boulevard
Santa Clara, CA 95051
United States
800 227 9770
http://www.agilent.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full-time employees17,000

Key executives

NameTitlePayExercisedYear born
Mr. Michael R. McMullenCEO, Pres & Director2.42MN/A1961
Mr. Robert W. McMahonSr. VP & CFO1.05MN/A1969
Mr. Michael TangSr. VP, Gen. Counsel & Sec.871.02k290.31k1974
Mr. Jacob ThaysenSr. VP and Pres of Life Sciences & Applied Markets Group956.32kN/A1975
Mr. Samraat S. RahaSr. VP and Pres of Diagnostics & Genomics Group797.78kN/A1973
Mr. Rodney GonsalvesPrincipal Accounting Officer, VP & Corp. ControllerN/AN/A1966
Dr. Darlene J. S. SolomonCTO & Sr. VPN/AN/A1959
Mr. Dominique P. GrauSr. VP of HR & Global CommunicationsN/AN/A1959
Ms. Allison BallmerSr. VP of Strategy & Corp. Devel.N/AN/AN/A
Mr. Richard A. BurdsallSr. VP of Global Infrastructure ServicesN/AN/A1963
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass and optical emission spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software, information management, and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment to produce synthesized oligonucleotide. It also offers immunohistochemistry, in situ hybridization, and hematoxylin and eosin staining and special staining; instruments, consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. It has collaboration agreement with SGS AXYS. The company was incorporated in 1999 and is headquartered in Santa Clara, California.

Corporate governance

Agilent Technologies, Inc.’s ISS governance QualityScore as of 26 September 2021 is 7. The pillar scores are Audit: 9; Board: 6; Shareholder rights: 8; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.